AstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports

 

Nov 4 (Reuters) – AstraZeneca made an about $10 billion offer to acquire rare-disease drugmaker Rhythm Pharmaceuticals, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Leroy Leo)

Brought to you by www.srnnews.com

Follow Us

WYSL LIVE

UPCOMING SHOWS

Recent Posts

Related Posts: